🇺🇸 FDA
Patent

US 9567393

Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid

granted A61KA61K38/1716A61K39/3955

Quick answer

US patent 9567393 (Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid) held by ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/1716, A61K39/3955